SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-22-000129
Filing Date
2022-01-04
Accepted
2022-01-04 14:40:18
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 9312
  Complete submission text file 0001654954-22-000129.txt   10647
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Mazar Andrew Paul (Reporting) CIK: 0001727393 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 22505320